Srebf1c preserves hematopoietic stem cell function and survival as a switch of mitochondrial metabolism

Stem Cell Reports. 2022 Mar 8;17(3):599-615. doi: 10.1016/j.stemcr.2022.01.011. Epub 2022 Feb 10.

Abstract

Mitochondria are fundamental but complex determinants for hematopoietic stem cell (HSC) maintenance. However, the factors involved in the regulation of mitochondrial metabolism in HSCs and the underlying mechanisms have not been fully elucidated. Here, we identify sterol regulatory element binding factor-1c (Srebf1c) as a key factor in maintaining HSC biology under both steady-state and stress conditions. Srebf1c knockout (Srebf1c-/-) mice display increased phenotypic HSCs and less HSC quiescence. In addition, Srebf1c deletion compromises the function and survival of HSCs in competitive transplantation or following chemotherapy and irradiation. Mechanistically, SREBF1c restrains the excessive activation of mammalian target of rapamycin (mTOR) signaling and mitochondrial metabolism in HSCs by regulating the expression of tuberous sclerosis complex 1 (Tsc1). Our study demonstrates that Srebf1c plays an important role in regulating HSC fate via the TSC1-mTOR-mitochondria axis.

Keywords: Srebf1c; TSC1; hematopoietic stem cell; mTOR; mitochondrial metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Division
  • Hematopoietic Stem Cells* / metabolism
  • Mammals / metabolism
  • Mice
  • Mitochondria / metabolism
  • Sirolimus / pharmacology
  • Sterol Regulatory Element Binding Protein 1
  • TOR Serine-Threonine Kinases* / metabolism

Substances

  • Srebf1 protein, mouse
  • Sterol Regulatory Element Binding Protein 1
  • TOR Serine-Threonine Kinases
  • Sirolimus